Dane Street Earns 2025 Great Place To Work Certification
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Dane Street announced that it has been awarded the prestigious Great Place To Work Certification™ for 2025. This marks the fourth year in a row the company has received this certification, dating back to 2022. The award is based entirely on what current employees say about their experience working at Dane Street.
'We are honored to have earned the Great Place to Work Certification for the 4th consecutive year. This is a credit to our entire employee base...We thank them for all their efforts,' said Dane Street President Greg Powers
Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.
'Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,' says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. 'By successfully earning this recognition, it is evident that Dane Street stands out as one of the top companies to work for, providing a great workplace environment for its employees.'
'We are honored to have earned the Great Place to Work Certification for the 4th consecutive year. This is a credit to our entire employee base, across all divisions and job functions, who work hard each day to embrace a culture of care that makes the entire team feel welcome and supported in a positive working environment. We thank them for all their efforts,' said Dane Street President Greg Powers.
According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified great workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work, and are twice as likely to be paid fairly, earn a fair share of the company's profits and have a fair chance at promotion.
About Great Place to Work Certification™
Great Place To Work® Certification™ is the most definitive 'employer-of-choice' recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
12 hours ago
- Business Upturn
Audien Atom Hearing Aid Releases 2025 Accessibility Update: Wireless Charging, Invisible Fit & Direct-to-Consumer Simplicity Reshape Hearing Aid Market
LOS ANGELES, June 28, 2025 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE Audien Hearing, a pioneering U.S.-based direct-to-consumer technology company, today announced its 2025 accessibility update for the Audien Atom Hearing Aid line. This update, driven by consumer needs and preferences, introduces innovative features such as non-prescription hearing support, wireless charging, and invisible in-ear design. As consumer behavior shifts towards self-managed wellness tools, Audien's direct-to-consumer solutions are gaining widespread interest across the tech-enabled hearing support landscape. With over one million customers served, the company's latest announcement addresses evolving demands for hearing aids that bypass traditional medical markups, require no prescriptions or fittings, and integrate effortlessly into daily life. The 2025 update, with its focus on affordability and accessibility, outlines specific improvements to the Atom One and Atom 2 models—both engineered for comfort, clarity, and cost transparency. What You'll Learn in This Accessibility Update Why demand for invisible, rechargeable hearing aids is increasing in 2025 How Audien Atom One and Atom 2 deliver performance without clinical pricing Where consumer search trends show growing interest in over-the-counter hearing support What new features like Atom Sound Technology™ and Comfort+ miniaturization mean for users How Audien aligns with the shift toward self-guided hearing wellness Hearing Aid Demand Surges as Consumers Seek Control, Clarity, and Simplicity More than 500 million people worldwide experience hearing loss, yet many remain underserved by traditional hearing aid models due to pricing, accessibility, or stigma. In 2025, hearing support is evolving from a clinical issue into a broader discussion about wellness and technology. Consumer behavior reflects this shift. Digital interest has grown substantially in phrases like 'wireless hearing aids,' 'affordable hearing help,' 'hearing aid without prescription,' and 'invisible ear canal device.' These keyword trends indicate a rising preference for performance, portability, and simplicity. Consumers are no longer willing to settle for outdated systems that require multi-step clinical approval and high out-of-pocket costs. Audien Hearing enters this market landscape with an accessibility-forward offering that aligns with these expectations: streamlined, rechargeable hearing support tools that consumers can order and use without medical consultations. The movement toward affordable, over-the-counter hearing wellness has found a foothold in the brand's direct-to-consumer strategy. 2025 Audien Product Announcement: Atom One and Atom 2 Offer Wireless and Minimalist Design Audien's 2025 update centers on its two flagship models: the Atom One and Atom 2. These devices are designed to provide non-prescription hearing support through technology-driven features that prioritize ease of use and affordability. Audien Atom One features: Compact design that fits discreetly into the ear canal Wireless magnetic USB-C charging Comfort+ ergonomics with a 20-hour battery life No prescription, fitting, or clinical visit is required Audien Atom 2 builds upon this foundation with: Four adjustable hearing modes for contextual use An extended battery duration Enhanced Comfort+ miniaturization for an improved fit Both models are part of Audien's broader goal to deliver accessible hearing amplification tools at a fraction of the traditional market price without compromising on usability or design. Atom One vs. Atom 2: Understanding the Differences and Use Case Scenarios The Atom One model is ideal for individuals seeking a low-maintenance, highly discreet solution for mild to moderate hearing support. Its ultra-compact form, simple magnetic charging, and streamlined single-mode amplification make it an excellent fit for first-time users or those prioritizing invisibility and ease of use in quiet or consistent environments. The Atom 2, meanwhile, expands on this offering with four distinct hearing modes. This added flexibility is designed for users who encounter a broader range of sound environments throughout the day, such as those working in public settings, teaching, or regularly transitioning between indoor and outdoor spaces. The extended battery life and upgraded Comfort+ fit also provide enhanced support for prolonged daily use. Both models are built around autonomy—removing the need for reprogramming, fitting appointments, or learning curves. The choice between them typically comes down to lifestyle, acoustic variability, and feature preferences. Rising Search Interest Reflects Market Shift Toward Self-Guided Hearing Solutions Across digital channels, interest in non-clinical hearing tools continues to expand. Search traffic has surged for key terms such as 'rechargeable hearing aids,' 'invisible ear canal device,' 'affordable hearing help,' 'hearing aid without prescription,' and 'OTC hearing support 2025.' These trends reveal a shift in consumer priorities, favoring autonomy, simplicity, and cost transparency over traditional in-clinic models. User forums and independent reviews consistently echo frustrations with legacy systems while spotlighting the appeal of modern, self-managed alternatives. The visibility of Audien Atom within these conversations signals not only product interest but a broader cultural embrace of hearing technology as a daily lifestyle accessory—comparable to fitness trackers or smart glasses—rather than a specialized clinical tool. Technology Spotlight: Inside the Audien Atom Series Audien's technical evolution is driven by consumer interest in modern wellness devices that provide clarity without complexity. The 2025 Atom product line is designed with user-friendliness in mind, featuring several core elements that ensure a seamless user experience: Atom Sound Technology™ This proprietary chip is designed to enhance speech clarity while minimizing ambient interference. It supports real-time speech amplification in environments where standard devices often struggle to function effectively. Magnetic Wireless Charging Architecture With USB-C wireless charging and 20–24-hour battery capacity, Audien devices eliminate the need for traditional hearing aid batteries. The portable charging case enhances convenience for travel and daily use. Comfort+ Miniaturization Design Both models prioritize discreet sizing and ergonomics. The Atom One is 22% smaller than previous iterations, enabling near-invisible wear that aligns with consumer expectations for subtlety and comfort. Multi-Mode Support (Atom 2 only) Four hearing modes provide customizable performance for various environments, from quiet indoor conversations to noisier public settings. This user-controlled feature enhances adaptability without requiring professional reprogramming. Together, these elements form a hearing solution designed for independent use—removing traditional barriers to auditory support and reframing what hearing devices can look and feel like in everyday life. User Journey and Market Reception The Audien Atom line has not only become a benchmark in the broader discussion about modern, self-directed hearing solutions, but it has also received overwhelmingly positive market reception. The public commentary reflects a shared desire for hearing support that avoids the burdens of clinic appointments and complex fittings. For many consumers—especially those exploring hearing devices for the first time—Audien offers a low-barrier entry point that feels accessible and intuitive. Recurring themes include: Preference for solutions that do not require hearing tests Appreciation for the plug-and-play nature of the Atom line The positive reception of the minimalist, invisible form factor Although some users voice skepticism regarding the effectiveness of low-cost hearing devices without personalization, others accept this trade-off in favor of convenience, discretion, and affordability. Hearing in Real Life: Consumer Profiles Reflect Use Across Ages and Lifestyles Audien's accessibility-forward approach is reflected in the diversity of its user base. A 62-year-old retiree in Arizona reported using the Atom One to comfortably engage in weekly book club meetings without feeling self-conscious. A 45-year-old elementary school teacher noted that the Atom 2 helped manage classroom acoustics by switching between noise-reduction modes throughout the school day. For younger users who may be sensitive to loud environments or early-stage hearing decline, the compact and wearable design offers seamless integration into everyday routines. Whether for navigating work meetings, family gatherings, or social events, the Atom line is being adopted by individuals seeking independence and functionality without a clinical label. These stories highlight the growing appeal of discreet, self-managed devices that serve both performance and lifestyle goals. Understanding the Regulatory Environment: Why Non-Prescription Hearing Aids Are Thriving Following the FDA's approval of over-the-counter (OTC) hearing aid sales in 2022, companies like Audien have gained traction by filling the gap between expensive medical devices and ineffective amplification gimmicks. The FDA's ruling opened the door for innovation and market competition, allowing consumers to access devices that support general hearing needs without navigating complex healthcare systems. In parallel, rising out-of-pocket healthcare costs have driven demand for self-managed wellness tools. As consumers take charge of their health journeys, the hearing aid category is benefiting from the same tailwinds as wearable fitness devices, vision correction platforms, and sleep optimization tools. Audien's product evolution reflects the influence of these macroeconomic and behavioral forces. Breaking Down the Cost Difference: Retail Models vs. Direct-to-Consumer Savings Traditional hearing aids can range from $3,000 to $7,000, often requiring multiple visits, tests, and service plans. These costs are frequently not covered by insurance and represent a significant financial burden for millions of consumers. Audien's direct-to-consumer approach eliminates intermediaries, showroom overhead, and the need for custom manufacturing. The result is a leaner, more transparent model that passes savings directly to users. Consumers pay a one-time cost for Atom One or Atom 2, with no contracts, subscriptions, or upsells. For individuals seeking mild to moderate hearing support, this model provides an opportunity to regain confidence in communication without incurring debt or navigating complex billing systems. Getting Started with Audien: What First-Time Users Can Expect New users can expect an intuitive setup experience. After unboxing, the devices can be fully charged using the included USB-C magnetic case in approximately 4 to 6 hours. Once charged, they are inserted directly into the ear canal and begin working immediately—no pairing, syncing, or calibration is required. Comfort and miniaturization ensure that users feel minimal pressure and visibility. Users are encouraged to wear the devices for short periods during the first few days to allow for a gentle adjustment period. Cleaning involves a soft brush or cloth, and a detailed maintenance guide is included for long-term care. The simplicity of this onboarding experience is one of Audien's most frequently cited advantages among first-time buyers. Direct Access and Consumer-Centric Availability Audien Atom Hearing Aids are available for purchase directly through the company's official website. The platform serves as both a product portal and an educational hub, offering instructional videos, specifications, and support materials to guide users through their experience. Key aspects of the direct-to-consumer model include: No prescription or audiologist consultation No clinic visit or retail markup Transparent product explanations with customer support access Audien does not provide diagnostic services or medical advice. Its offerings are wellness-aligned, non-clinical tools designed to enhance hearing clarity in ordinary daily situations. The company maintains compliance with consumer protection standards and clearly communicates the scope of its product applications. Final Observations: Hearing Wellness as a Lifestyle Choice The hearing support industry is evolving. Once viewed primarily as a domain of clinical intervention, hearing tools are now being reframed as part of the broader personal health and technology marketplace. Similar to shifts in vision correction, sleep optimization, and fitness tracking, the hearing space is embracing self-serve functionality and consumer-first accessibility. Audien's 2025 update reflects this transformation. With a focus on wireless charging, discreet design, and ease of use, the company's Atom series aligns with growing expectations for wellness products that are transparent, approachable, and compatible with modern life. These tools are not just for those with medical diagnoses—they're for anyone seeking more precise sound in everyday conversations. As awareness grows and consumer empowerment takes center stage, the Atom line may signal the future of how hearing wellness is delivered: directly, affordably, and without complexity. About Audien Hearing™ Audien Hearing™ is a U.S.-based wellness technology company focused on simplifying access to hearing support. Founded to address the cost and complexity of traditional hearing aids, Audien develops in-ear, rechargeable devices that emphasize user independence and design simplicity. All devices are offered through the company's online platform and are intended for non-clinical use. Audien does not provide diagnostic services or medical treatment. Its mission is to empower consumers to manage hearing support in a transparent, affordable, and approachable way. Contact Disclaimers This release contains general information only and does not constitute medical advice. The products referenced are not intended to diagnose, treat, cure, or prevent any disease. The Food and Drug Administration has evaluated no statements in this release. Individuals should consult with a qualified healthcare provider for any medical concerns. Results may vary by user. Audien Hearing does not provide audiological testing, clinical consultations, or professional medical services. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Wire
a day ago
- Business Wire
Rocket Lab Completes Record Launch Turnaround From Launch Complex 1, Successfully Deploys 68 th Electron Mission
MAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab Corporation (Nasdaq: RKLB) ('Rocket Lab' or 'the Company'), a global leader in launch services and space systems, today successfully launched its 68th Electron rocket to deploy a single satellite to space for a confidential commercial customer. The mission was the second of two launches from the same launch site in less than 48 hours, a new launch record for the Company as it continues to deliver dedicated, repeatable and reliable access to space for satellite operators. The 'Symphony In The Stars' mission lifted-off from Rocket Lab Launch Complex 1 in Mahia, New Zealand on June 28 th (7:08 p.m./07:08 UTC) to deploy a single spacecraft to a 650km circular Earth orbit. The mission was the first of two dedicated launches for the new customer on Electron booked less than four months ago, with a second mission scheduled before the end of 2025. Rocket Lab has now completed four launches in June for commercial satellite constellation operators, underscoring Electron's consistent performance and rapid deployment capabilities as the world's leading small launcher: the 'Full Stream Ahead' mission on June 3 rd; 'The Mountain God Guards' mission on June 11 th; 'Get The Hawk Outta Here' launched on June 26 th UTC, and today's 'Symphony In The Stars' mission. Rocket Lab Founder and CEO, Sir Peter Beck, says: 'Electron has demonstrated once again that it is the gold standard for responsive and reliable space access for small satellites. The future of space is built on proven performance, and Electron continues to deliver against a stacked launch manifest this year. Congratulations to the team on achieving its fastest launch turnaround yet between two missions from Launch Complex 1. This launch was also a quick-turn mission to meet our customer's mission requirements, and we're looking forward to doing it again later this year.' 'Symphony In The Stars' was Rocket Lab's tenth Electron mission of 2025 and its 68th launch overall. With 100% mission success so far this year, Electron continues to deliver reliable deployment amid an increasing launch cadence and rapid contract-to-launch timelines. Launch images: About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, a family of spacecraft platforms, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered over 200 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's spacecraft platforms have been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words 'believe,' 'may,' 'will,' 'estimate,' 'potential,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'strategy,' 'future,' 'could,' 'would,' 'project,' 'plan,' 'target,' and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the 'SEC'), accessible on the SEC's website at and the Investor Relations section of our website at which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Business Wire
a day ago
- Business Wire
SBC Medical added to membership of Russell 3000 ® Index
IRVINE, Calif.--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical'), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000 ® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. Membership in the Russell 3000 ® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or small-cap Russell 2000 ® Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. Fiona Bassett, CEO of FTSE Russell, An LSEG Business, comments: 'The Russell indexes have continuously adapted to the evolving dynamic US economy, and it's crucial to fully recalibrate the suite of Russell US Indexes, ensuring the indexes maintain an accurate representation of the market. The transition to a semi-annual reconstitution frequency from 2026 will ensure our indexes continue to represent the market and maintain the purpose of the index as a portfolio benchmark.' For more information on the Russell 3000 ® Index and the Russell indexes reconstitution, go to the 'Russell Reconstitution' section on the FTSE Russell website. About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit About FTSE Russell, an LSEG Business FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering. FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit FTSE Russell. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' 'targets' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at
